These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 8764380

  • 1. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.
    Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M.
    J Pharmacol Exp Ther; 1996 Jul; 278(1):441-6. PubMed ID: 8764380
    [Abstract] [Full Text] [Related]

  • 2. Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis.
    Dahl ML, Johansson I, Bertilsson L, Ingelman-Sundberg M, Sjöqvist F.
    J Pharmacol Exp Ther; 1995 Jul; 274(1):516-20. PubMed ID: 7616439
    [Abstract] [Full Text] [Related]

  • 3. Concordance of P450 2D6 (debrisoquine hydroxylase) phenotype and genotype: inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extensive metabolizers.
    Evans WE, Relling MV.
    Pharmacogenetics; 1991 Dec; 1(3):143-8. PubMed ID: 1688245
    [Abstract] [Full Text] [Related]

  • 4. Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.
    Johansson I, Lundqvist E, Bertilsson L, Dahl ML, Sjöqvist F, Ingelman-Sundberg M.
    Proc Natl Acad Sci U S A; 1993 Dec 15; 90(24):11825-9. PubMed ID: 7903454
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians.
    McLellan RA, Oscarson M, Seidegård J, Evans DA, Ingelman-Sundberg M.
    Pharmacogenetics; 1997 Jun 15; 7(3):187-91. PubMed ID: 9241658
    [Abstract] [Full Text] [Related]

  • 14. Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis.
    Hou ZY, Chen CP, Yang WC, Lai MD, Buchert ET, Chung HM, Pickle LW, Woosley RL.
    Clin Pharmacol Ther; 1996 Apr 15; 59(4):411-7. PubMed ID: 8612385
    [Abstract] [Full Text] [Related]

  • 15. Phenotype/genotype relationships for the cytochrome P450 enzyme CYP2D6 in rheumatoid arthritis: influence of drug therapy and disease activity.
    Beyeler C, Daly AK, Armstrong M, Astbury C, Bird HA, Idle JR.
    J Rheumatol; 1994 Jun 15; 21(6):1034-9. PubMed ID: 7932410
    [Abstract] [Full Text] [Related]

  • 16. Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population.
    Broly F, Gaedigk A, Heim M, Eichelbaum M, Morike K, Meyer UA.
    DNA Cell Biol; 1991 Oct 15; 10(8):545-58. PubMed ID: 1681816
    [Abstract] [Full Text] [Related]

  • 17. Ultrarapid metabolizers of debrisoquine: characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene.
    Løvlie R, Daly AK, Molven A, Idle JR, Steen VM.
    FEBS Lett; 1996 Aug 19; 392(1):30-4. PubMed ID: 8769309
    [Abstract] [Full Text] [Related]

  • 18. Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population.
    Roh HK, Dahl ML, Johansson I, Ingelman-Sundberg M, Cha YN, Bertilsson L.
    Pharmacogenetics; 1996 Oct 19; 6(5):441-7. PubMed ID: 8946476
    [Abstract] [Full Text] [Related]

  • 19. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P, Cáceres MC, Pozo-Guisado E, Wong ML, Licinio J, Llerena A.
    Biotechniques; 2005 Oct 19; 39(4):571-4. PubMed ID: 16235570
    [Abstract] [Full Text] [Related]

  • 20. Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls.
    Sugimura H, Caporaso NE, Shaw GL, Modali RV, Gonzalez FJ, Hoover RN, Resau JH, Trump BF, Weston A, Harris CC.
    Carcinogenesis; 1990 Sep 19; 11(9):1527-30. PubMed ID: 1976046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.